Information about Scaldis Pharma
My details
*
*
*

Scaldis Pharma (SRL)

Company information

Status
Active

Enterprise number

BE0803.923.429

VAT liability
Yes
Established
13-07-2023
Last balance sheet year
2025
Company size
Micro 0,7 FTE
Legal form
Société à responsabilité limitée (SRL)
Commercial name
Qualicon Development
Principal activity
Engineering activities and related technical consultancy
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Scaldis Pharma

2025 2024 2023
Income statement
Profit/Loss € -14,039 -158% € 24,009 319% € 5,727
Gross margin € 54,532 50% € 36,248 299% € 9,087
Balance sheet
Balance sheet total € 251,161 394% € 50,842 44% € 35,427
Equity € 5,697 -84% € 34,735 224% € 10,727
Debts € 245,464 > 1000% € 16,106 -35% € 24,701
Other
Employees 0.7

Publications from Scaldis Pharma

Date Publication
13-11-2026 Modification(s) Articles of Association (NL)
17-07-2023 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Scaldis Pharma?
The VAT number of Scaldis Pharma is BE 0803.923.429.
Wat is the PEPPOL ID of Scaldis Pharma?
The PEPPOL ID of Scaldis Pharma is 0208:0803923429. Log in or start a free trial to see the full overview.
When was Scaldis Pharma founded?
Scaldis Pharma was founded on 13-07-2023.
What is the address of Scaldis Pharma?
The current registered office of Scaldis Pharma is located at Kapittelstraat 75, 9310 Aalst.
When was the last time Scaldis Pharma filed their annual financial statements?
The most recent financial statements of Scaldis Pharma were filed on 30-06-2026.
How many employees does Scaldis Pharma have?
There are 0,7 FTEs working at Scaldis Pharma according to the staff figures in the most recent financial statements.
What is the annual turnover of Scaldis Pharma?
At the time of its most recent financial statements, Scaldis Pharma did not publish any turnover figures. Scaldis Pharma reported a gross margin of €54,532.06.